CTC and prostate cancer
30th OctoberAR-V7 Linked to Targeted Therapy Resistance in Prostate Cancer
Using the AdnaGen Test Emmanuel S. Antonarakis team at John associated the androgen receptor splice variant 7 with resistance to therapies for metastatic castration-resistant prostate cancer.
> Learn more about the AdnaGen test for CTCs